0

Coronary Risk Factors Collection
 141-160 of 1900 Articles
Articles |  15 September 2009
The Net Value of Health Care for Patients With Type 2 Diabetes, 1997 to 2005
Karen N. Eggleston, PhD; Nilay D. Shah, PhD; Steven A. Smith, MD; et al.
Ann Intern Med. 2009;151(6):386-393. doi:10.7326/0003-4819-151-6-200909150-00003
Reviews |  15 September 2009 FREE
Systematic Review: Glucose Control and Cardiovascular Disease in Type 2 Diabetes
Tanika N. Kelly, PhD; Lydia A. Bazzano, MD, PhD; Vivian A. Fonseca, MD; et al.
Ann Intern Med. 2009;151(6):394-403. doi:10.7326/0003-4819-151-6-200909150-00137
Reviews |  15 September 2009
Meta-analysis: Retinal Vessel Caliber and Risk for Coronary Heart Disease
Kevin McGeechan, MBiostat; Gerald Liew, MBBS, MMed; Petra Macaskill, PhD; et al.
Ann Intern Med. 2009;151(6):404-413. doi:10.7326/0003-4819-151-6-200909150-00005
Articles |  1 September 2009
Effects of a Mediterranean-Style Diet on the Need for Antihyperglycemic Drug Therapy in Patients With Newly Diagnosed Type 2 Diabetes: A Randomized Trial
Katherine Esposito, MD, PhD; Maria Ida Maiorino, MD; Miryam Ciotola, MD; et al.
Ann Intern Med. 2009;151(5):306-314. doi:10.7326/0003-4819-151-5-200909010-00004
Academia and the Profession |  18 August 2009 FREE
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPRISMA: Explanation and Elaboration
Alessandro Liberati, MD, DrPH; Douglas G. Altman, DSc; Jennifer Tetzlaff, BSc; et al.
Ann Intern Med. 2009;151(4):W-65-W-94. doi:10.7326/0003-4819-151-4-200908180-00136
Ideas and Opinions |  21 July 2009
Cholesterol Control Beyond the Clinic: New York City's Trans Fat Restriction
Sonia Y. Angell, MD, MPH; Lynn Dee Silver, MD, MPH; Gail P. Goldstein, MPH; et al.
Ann Intern Med. 2009;151(2):129-134. doi:10.7326/0003-4819-151-2-200907210-00010
Articles |  7 July 2009 FREE
Effect of Telmisartan on Renal Outcomes: A Randomized Trial
Johannes F.E. Mann, MD; Roland E. Schmieder, MD; Leanne Dyal, MSc; et al.
Ann Intern Med. 2009;151(1):1-10. doi:10.7326/0003-4819-151-1-200907070-00122
Articles |  7 July 2009 FREE
Effect of Candesartan on Microalbuminuria and Albumin Excretion Rate in Diabetes: Three Randomized Trials
Rudy Bilous, MD; Nish Chaturvedi, MD; Anne Katrin Sjølie, MD; et al.
Ann Intern Med. 2009;151(1):11-20. doi:10.7326/0003-4819-151-1-200907070-00120
Articles |  16 June 2009
Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients: A Randomized Trial
David J. Becker, MD; Ram Y. Gordon, MD; Steven C. Halbert, MD; et al.
Ann Intern Med. 2009;150(12):830-839. doi:10.7326/0003-4819-150-12-200906160-00006
Reviews |  16 June 2009
Narrative Review: Statin-Related Myopathy
Tisha R. Joy, MD; Robert A. Hegele, MD
Ann Intern Med. 2009;150(12):858-868. doi:10.7326/0003-4819-150-12-200906160-00009
Editorials |  16 June 2009
Balancing Randomized Trials With Anecdote
Paul S. Phillips, MD
Ann Intern Med. 2009;150(12):885-886. doi:10.7326/0003-4819-150-12-200906160-00014
Articles |  2 June 2009
Two Risk-Scoring Systems for Predicting Incident Diabetes Mellitus in U.S. Adults Age 45 to 64 Years
Henry S. Kahn, MD; Yiling J. Cheng, MD, PhD; Theodore J. Thompson, MS; et al.
Ann Intern Med. 2009;150(11):741-751. doi:10.7326/0003-4819-150-11-200906020-00002
Reviews |  2 June 2009
Narrative Review: The Emerging Clinical Implications of the Role of Aldosterone in the Metabolic Syndrome and Resistant Hypertension
James R. Sowers, MD; Adam Whaley-Connell, DO; Murray Epstein, MD
Ann Intern Med. 2009;150(11):776-783. doi:10.7326/0003-4819-150-11-200906020-00005
Academia and the Profession |  2 June 2009
Advances in Measuring the Effect of Individual Predictors of Cardiovascular Risk: The Role of Reclassification Measures
Nancy R. Cook, ScD; Paul M Ridker, MD
Ann Intern Med. 2009;150(11):795-802. doi:10.7326/0003-4819-150-11-200906020-00007
Ideas and Opinions |  2 June 2009
Glycemic Control in Type 2 Diabetes: Time for an Evidence-Based About-Face?
Victor M. Montori, MD, MSc; Mercè Fernández-Balsells, MD
Ann Intern Med. 2009;150(11):803-808. doi:10.7326/0003-4819-150-11-200906020-00008
Editorials |  2 June 2009
Predicting Risk for Diabetes: Choosing (or Building) the Right Model
William H. Herman, MD, MPH
Ann Intern Med. 2009;150(11):812-814. doi:10.7326/0003-4819-150-11-200906020-00010
Academia and the Profession |  19 May 2009
Current Guidelines for Using Angiotensin-Converting Enzyme Inhibitors and Angiotensin II–Receptor Antagonists in Chronic Kidney Disease: Is the Evidence Base Relevant to Older Adults?
Ann M. O'Hare, MD; James S. Kaufman, MD; Kenneth E. Covinsky, MD, MPH; et al.
Ann Intern Med. 2009;150(10):717-724. doi:10.7326/0003-4819-150-10-200905190-00010
Articles |  21 April 2009 FREE
Differences in Control of Cardiovascular Disease and Diabetes by Race, Ethnicity, and Education: U.S. Trends From 1999 to 2006 and Effects of Medicare Coverage
J. Michael McWilliams, MD, PhD; Ellen Meara, PhD; Alan M. Zaslavsky, PhD; et al.
Ann Intern Med. 2009;150(8):505-515. doi:10.7326/0003-4819-150-8-200904210-00005
Articles |  21 April 2009 FREE
Using a Drug Facts Box to Communicate Drug Benefits and Harms: Two Randomized Trials
Lisa M. Schwartz, MD, MS; Steven Woloshin, MD, MS; H. Gilbert Welch, MD, MPH
Ann Intern Med. 2009;150(8):516-527. doi:10.7326/0003-4819-150-8-200904210-00106
Articles |  21 April 2009
Joint Effects of Common Genetic Variants on the Risk for Type 2 Diabetes in U.S. Men and Women of European Ancestry
Marilyn C. Cornelis, PhD; Lu Qi, MD, PhD; Cuilin Zhang, MD, PhD; et al.
Ann Intern Med. 2009;150(8):541-550. doi:10.7326/0003-4819-150-8-200904210-00008
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)